6-K ·Filed Jul 13, 2026
Notable filing: 6-K
Actionable Insight • Neutral
This is a routine weekly update with no new information. The buyback is progressing as expected at a steady pace (~DKK 315M/week on average). No trading signal from this filing.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60Entry
$49.28
T+0 close · Jul 13, 2026 · via day close
Latest settled
−23.84%
T+60 · $37.53
vs SPY
−27.84%
α at T+60
Horizons
All settled
through T+60
- T+0 · Jul 13 $49.28entry
- T+1 · 4mo ago −0.43%α −0.78% · $49.07
- T+5 · 4mo ago +2.11%α +2.90% · $50.32
- T+20 · 3mo ago −3.15%α −6.33% · $47.73
- T+60 · 29d ago −23.84%α −27.84% · $37.53
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
Novo Nordisk filed a routine 6-K providing a weekly update on its ongoing DKK 15 billion share repurchase program. There are no new financial results, guidance changes, or material corporate events in this filing.
Key Facts
- Total share repurchase program of up to DKK 15 billion running from 4 Feb 2026 to 3 Feb 2027.
- Since 4 Feb 2026, repurchased 23,984,179 B shares at avg price DKK 272.45 for total DKK 6,534,545,458.
- As of 10 Jul 2026, Novo Nordisk holds 41,169,480 B shares as treasury shares, equal to 0.9% of share capital.
- Under the sub-program started 6 May 2026, up to DKK 11.2 billion in B shares may be repurchased through 1 Feb 2027.
Financial Impact
DKK 15 billion (approx $2.1B) buyback program; ~DKK 6.5B executed to date, ~DKK 8.5B remaining.
dilutionshare countcapital return
Risk Factors
- No material risks disclosed in this filing.
Market Snapshot
Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
35% bullish (37 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-004596 |
| Document: 0001171843-26-004596-index-headers.html | 0001171843-26-004596 |
| Document: 0001171843-26-004596-index.html | 0001171843-26-004596 |
| Document: 0001171843-26-004596.txt | 0001171843-26-004596 |
37 reports for NVO
83% Hit rate @ T+20 Went positive at some point 6 of 6 best @ T+60▲ +23.56%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 4, 2026 today | 6-K | $42.95 | awaiting T+20 | awaiting T+20 | $42.60 (−0.83%) |
Nov 3, 2026 1d ago | 6-K | $40.56 | awaiting T+20 | awaiting T+20 | $42.60 (+5.02%) |
Oct 26, 2026 9d ago | 6-K | $39.13 | awaiting T+20 | awaiting T+20 | $42.60 (+8.86%) |
Oct 26, 2026 9d ago | Court Ruling | $38.67 | awaiting T+20 | awaiting T+20 | $42.60 (+10.15%) |
Oct 19, 2026 16d ago | 6-K | $38.42 | awaiting T+20 | awaiting T+20 | $42.60 (+10.87%) |
Oct 13, 2026 22d ago | 6-K | $38.06 | awaiting T+20 | awaiting T+20 | $42.60 (+11.92%) |
Oct 6, 2026 29d ago | 6-K | $37.53 $40.19 | ▲ +7.09% | ▲ +10.26% | $42.60 (+13.50%) |
Sep 28, 2026 5w ago | 6-K | $38.71 $38.95 | ▲ +0.61% | ▲ +0.64% | $42.60 (+10.04%) |
Sep 23, 2026 6w ago | Court Ruling | $38.62 $39.43 | ▲ +2.10% | ▲ +2.52% | $42.60 (+10.29%) |
Sep 21, 2026 6w ago | 6-K | $39.80 $38.42 | ▼ −3.47% | ▼ −2.56% | $42.60 (+7.02%) |
Showing 10 of 37
US Market Status
Market Open · Closes in 1h 27m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers